GPs likely to see increased workload due to ramipril shortage
A shortage of ramipril, a commonly prescribed blood pressure medication, is expected to increase workload for GPs due to supply disruptions. The UK Government has issued a serious shortage protocol notice, limiting patients to one month's supply of ramipril 1.25mg capsules.
A shortage of ramipril, a blood pressure medication, will impact general practice, according to a leading GP. The UK Government has issued a serious shortage protocol notice for ramipril 1.25mg capsules, limiting patients to one month's supply. Pharmacies can issue fewer capsules than prescribed to alleviate supply disruptions. Three million items of ramipril are prescribed monthly in England. Professor Azeem Majeed warned that supply disruptions will create problems for patients, GPs, and pharmacies. The Department of Health and Social Care stated that other low-dose ACE inhibitors and ARBs remain available. The National Pharmacy Association chairman, Olivier Picard, urged the Government to allow pharmacists to substitute ramipril prescriptions to avoid patients having to revisit their GP.
This content was automatically generated and/or translated by AI. It may contain inaccuracies. Please refer to the original sources for verification.